2025
SJR Q2
JCR Q2 · 4,1
OA
2 matched articles
ESCI
Journal detail
ImmunoTargets and Therapy
- Publisher
- Dove Medical Press Ltd
- Country
- New Zealand · Pacific Region
- Type
- journal
- ISSN
-
22531556
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,11
- Quartile Q2
- H-Index 36
- Cites/doc 3,94
- Docs (3y) 76
- Cites (3y) 324
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,1
- 5Y JIF 6,3
- JCI 0,65
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Immunology Q2
- Immunology and Allergy Q2
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Immunology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 1,11 | 4,1 | 6,3 | 0,65 | Q3 | 36 |
| 2024 | Q1 | Q2 | 2,291 | 4,4 | 7,9 | 0,71 | Q2 | 29 |
| 2023 | Q1 | Q1 | 2,14 | 6,2 | 8,1 | 0,72 | Q2 | 29 |
| 2022 | Q1 | — | 1,681 | 7,2 | 8,3 | 0,73 | Q2 | 29 |
| 2021 | — | — | — | — | — | 0,88 | Q2 | 29 |
| 2020 | Q4 | — | 0,256 | — | — | 1,03 | Q2 | 29 |
| 2019 | Q1 | — | 1,703 | — | — | — | — | 29 |
| 2017 | — | — | — | — | — | — | — | 29 |
| 2016 | — | — | — | — | — | — | — | 29 |
| 2015 | — | — | — | — | — | — | — | 29 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | ESCI | Q2 | Q3 | 70/183 |
| 2024 | IMMUNOLOGY | ESCI | Q2 | Q2 | 58/183 |
| 2023 | IMMUNOLOGY | ESCI | Q1 | Q2 | 34/181 |
| 2022 | IMMUNOLOGY | ESCI | — | Q2 | — |
| 2021 | IMMUNOLOGY | ESCI | — | Q2 | — |
| 2020 | IMMUNOLOGY | ESCI | — | Q2 | — |